HUTCHMED (China) Limited (HCM)
NASDAQ: HCM · Real-Time Price · USD
13.92
-0.29 (-2.04%)
At close: May 12, 2025, 4:00 PM
14.47
+0.55 (3.95%)
After-hours: May 12, 2025, 7:21 PM EDT
HUTCHMED (China) Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for HUTCHMED (China) stock has a target of 19, which predicts an increase of 36.49% from the current stock price of 13.92.
Analyst Consensus: Hold
* Price targets were last updated on Aug 1, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for HUTCHMED (China) is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
Buy | 1 | 1 | 1 | 1 | 1 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 3 | 3 | 3 | 3 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Goldman Sachs | Goldman Sachs | Hold Maintains $17 → $19 | Hold | Maintains | $17 → $19 | +36.49% | Aug 1, 2024 |
Deutsche Bank | Deutsche Bank | Hold → Strong Buy Upgrades $20 → $22 | Hold → Strong Buy | Upgrades | $20 → $22 | +58.76% | Nov 24, 2023 |
Goldman Sachs | Goldman Sachs | Hold Maintains $15 → $17 | Hold | Maintains | $15 → $17 | +22.13% | Nov 10, 2023 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $50 | Buy | Reiterates | $50 | +259.20% | Sep 5, 2023 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $50 | Buy | Reiterates | $50 | +259.20% | Jul 24, 2023 |
Financial Forecast
Revenue This Year
723.84M
from 630.20M
Increased by 14.86%
Revenue Next Year
865.28M
from 723.84M
Increased by 19.54%
EPS This Year
0.47
from 0.04
Increased by 1,063.77%
EPS Next Year
0.13
from 0.47
Decreased by -71.46%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 841.0M | 1.0B | 1.3B | ||
Avg | 723.8M | 865.3M | 1.0B | ||
Low | 646.5M | 715.4M | 798.7M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 33.4% | 42.4% | 47.0% | ||
Avg | 14.9% | 19.5% | 19.8% | ||
Low | 2.6% | -1.2% | -7.7% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | 0.71 | 0.23 | 0.39 |
Avg | 0.47 | 0.13 | 0.21 |
Low | 0.28 | -0.08 | 0.11 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 1,677.2% | -50.2% | 195.6% |
Avg | 1,063.8% | -71.5% | 57.1% |
Low | 598.3% | - | -19.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.